Abstract:Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma arising from the nasopharyngeal mucosal lining. Diagnosis of NPC at early stage can improve the outcome of patients and facilitate reduction in cancer mortality. The most significant change between cancer cells and normal cells is the variation of cell nucleus. Therefore, accurately detecting the biochemical changes in nucleus between cancer cells and normal cells has great potential to explore diagnostic molecular markers for NPC. Highly sensitive surface-enhanced Raman scattering (SERS) could reflect the biochemical changes in the process of cell cancerization at the molecular level. However, rapid nuclear targeting SERS detection remains a challenge. Results: A novel and accurate nuclear-targeting SERS detection method based on electroporation was proposed. With the assistance of electric pulses, nuclear-targeting nanoprobes were rapidly introduced into different NPC cells (including CNE1, CNE2, C666 cell lines) and normal nasopharyngeal epithelial cells (NP69 cell line), respectively. Under the action of nuclear localization signaling peptides (NLS), the nanoprobes entering cells were located to the nucleus, providing high-quality nuclear SERS signals. Hematoxylin and eosin (H&E) staining and in situ cell SERS imaging confirmed the excellent nuclear targeting performance of the nanoprobes developed in this study. The comparison of SERS signals indicated that there were subtle differences in the biochemical components between NPC cells and normal nasopharyngeal cells. Furthermore, SERS spectra combined with principal component analysis (PCA) and linear discriminant analysis (LDA) were employed to diagnose and distinguish NPC cell samples, and high sensitivity, specificity, and accuracy were obtained in the screening of NPC cells from normal nasopharyngeal epithelial cells. Significance: To the best of our knowledge, this is the first study that employing nuclear-targeting SERS testing to screen nasopharyngeal carcinoma cells. Based on the electroporation technology, nanoprobes can be rapidly introduced into living cells for intracellular biochemical detection. Nuclear-targeting SERS detection can analyze the biochemical changes in the nucleus of cancer cells at the molecular level, which has great potential for early cancer screening and cytotoxicity analysis of anticancer drugs.

Nasopharyngeal carcinoma cell screening based on the electroporation-SERS spectroscopy

Nasopharyngeal carcinoma cell screening based on nuclear targeting Surface-Enhanced Raman Scattering (SERS) detection

Human Blood Test Based on Surface-Enhanced Raman Spectroscopy Technology Using Different Excitation Light for Nasopharyngeal Cancer Detection

Highly Efficient Blood Protein Analysis Using Membrane Purification Technique and Super-Hydrophobic SERS Platform for Precise Screening and Staging of Nasopharyngeal Carcinoma

Noninvasive Detection of Nasopharyngeal Carcinoma Based on Saliva Proteins Using Surface-Enhanced Raman Spectroscopy

Non-Invasive Detection of Nasopharyngeal Carcinoma Using Saliva Surface-Enhanced Raman Spectroscopy

The Application Value of Raman Spectra for Serum in Early Nasopharyngeal Carcinoma Diagnosis

Molecular separation-assisted label-free SERS combined with machine learning for nasopharyngeal cancer screening and radiotherapy resistance prediction

Assessment of the Radiotherapy Effect for Nasopharyngeal Cancer Using Plasma Surface-Enhanced Raman Spectroscopy Technology

Surface-enhanced Raman Scattering Spectroscopy for Potential Noninvasive Nasopharyngeal Cancer Detection

Detection of Nasopharyngeal Carcinoma Based on Human Saliva Surface-Enhanced Raman Spectroscopy

Early discrimination of nasopharyngeal carcinoma based on tissue deoxyribose nucleic acid surface-enhanced Raman spectroscopy analysis.

Label-free Blood Plasma Test Based on Surface-Enhanced Raman Scattering for Tumor Stages Detection in Nasopharyngeal Cancer.

Test of label-free Nasopharyngeal carinoma tissue at different stages by Raman spectroscopy

Raman Spectra and Discrimination of NPC Cell Line CNE1 and Normal Nasopharyngeal Cell Line NP69

Diagnosis of nasopharyngeal carcinoma from serum samples using hyperspectral imaging combined with a chemometric method.

Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection

Identification of different tumor states in nasopharyngeal cancer using surface-enhanced Raman spectroscopy combined with Lasso-PLS-DA algorithm

Nasopharyngeal Cancer Detection Based on Blood Plasma Surface-Enhanced Raman Spectroscopy and Multivariate Analysis.

SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma